Comparative binding and toxicity of saxitoxin and saxitoxinol in mice and in cultured cells

S M Naseem1, D A Creasia

  • 1U.S.Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD-21702-5011, USA. dr._syed_naseem@ftdetrck-ccmail.army.mil

Biochemistry and Molecular Biology International
|February 1, 1997
PubMed

Insights

This study shows that tritium-labeled saxitoxinol (3H-STXOL) can identify saxitoxin (STX) receptors on cell surfaces. Unlike STX, 3H-STXOL is non-toxic and its tritium label is stable, making it a valuable tool.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Saxitoxin (STX) is a potent blocker of voltage-gated sodium channels.
  • Understanding STX receptor binding is crucial for neurobiology and toxicology.
  • Existing methods for studying STX receptors have limitations.

Purpose of the Study:

  • To characterize the binding of saxitoxinol (STXOL), an STX analog, to STX receptors.
  • To evaluate the utility of tritium-labeled STXOL (3H-STXOL) as a research tool.
  • To compare the binding properties and toxicity of STX and STXOL.

Main Methods:

  • Binding assays were performed using neuroblastoma, peritoneal macrophage, hepatocyte, and PC-12 cell lines.
  • Saturation, competition, association, and dissociation kinetics were analyzed.
  • Toxicity was assessed in mice following intratracheal instillation.

Main Results:

  • 3H-STXOL bound to cell-surface sites identical to those for 3H-STX, confirming them as STX receptors.
  • Kinetic analyses showed consistent binding measurements for both STX and STXOL.
  • STXOL demonstrated non-toxicity in mice, a significant advantage over STX.
  • The tritium label on 3H-STXOL is non-exchangeable, enhancing assay reliability.

Conclusions:

  • 3H-STXOL is a reliable and non-toxic radioligand for identifying and studying STX receptors.
  • This method allows for accurate receptor identification at physiological temperatures (37°C).
  • 3H-STXOL offers a significant advancement for research on sodium channel pharmacology and neurotoxicology.